Insights

Innovative Technology Adoption Magnolia Medical Technologies has developed the evidence-based Steripath platform and launched Steripath Gen2 with integrated syringe, demonstrating a commitment to advancing diagnostic accuracy and addressing challenging patient populations. This ongoing product innovation presents opportunities to expand sales within hospitals seeking cutting-edge solutions for bloodstream infection diagnostics.

Strong Healthcare Partnerships Recent collaborations with large hospital systems and corporate partners like Becton Dickinson highlight Magnolia’s ability to form strategic alliances. These partnerships enhance market reach and create avenues for joint marketing and sales efforts, making them an attractive target for potential new collaborations or distribution channels.

Leadership Expansion The appointment of experienced executives such as a new CEO and SVP of Sales signals a focus on scaling commercial operations and market penetration. Engaging with the company's leadership team could open opportunities to present innovative solutions tailored to hospitals aiming to reduce diagnostic errors and improve patient safety.

Market-Driven Focus Magnolia’s core mission to eliminate diagnostic errors and reduce false-positive sepsis and CLABSI cases aligns with the increasing emphasis on precision medicine and antimicrobial stewardship. These market trends create opportunities to position Magnolia’s solutions as essential tools for hospitals prioritizing quality care and cost reduction.

Financial Growth Potential With revenue estimated between $10 million and $25 million and recent funding of $46 million, Magnolia Medical shows strong growth potential. This financial backdrop supports expansion into new healthcare markets and adoption of their innovative diagnostic devices, making it a compelling proposition for sales efforts focused on high-impact hospital systems.

Magnolia Medical Technologies Tech Stack

Magnolia Medical Technologies uses 8 technology products and services including Linkedin Insight Tag, WordPress, Liquid Web, and more. Explore Magnolia Medical Technologies's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • WordPress
    Content Management System
  • Liquid Web
    Platform As A Service
  • Java
    Programming Languages
  • Showpad
    Sales Enablement
  • reCAPTCHA
    Security
  • ZURB Foundation
    UI Frameworks
  • Twitter
    Widgets

Media & News

Magnolia Medical Technologies's Email Address Formats

Magnolia Medical Technologies uses at least 1 format(s):
Magnolia Medical Technologies Email FormatsExamplePercentage
First.Last@magnolia-medical.comJohn.Doe@magnolia-medical.com
97%
First.Middle@magnolia-medical.comJohn.Michael@magnolia-medical.com
2%
Last@magnolia-medical.comDoe@magnolia-medical.com
1%

Frequently Asked Questions

Where is Magnolia Medical Technologies's headquarters located?

Minus sign iconPlus sign icon
Magnolia Medical Technologies's main headquarters is located at 220 West Mercer Street Suite 100 Seattle, Washington 98119 United States. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Magnolia Medical Technologies's phone number?

Minus sign iconPlus sign icon
You can contact Magnolia Medical Technologies's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Magnolia Medical Technologies's official website and social media links?

Minus sign iconPlus sign icon
Magnolia Medical Technologies's official website is magnolia-medical.com and has social profiles on LinkedInCrunchbase.

What is Magnolia Medical Technologies's NAICS code?

Minus sign iconPlus sign icon
Magnolia Medical Technologies's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Magnolia Medical Technologies have currently?

Minus sign iconPlus sign icon
As of April 2026, Magnolia Medical Technologies has approximately 107 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Commercial Officer: C. W.Chief Financial Officer: P. O.Vice President Of National Strategic Accounts: D. F.. Explore Magnolia Medical Technologies's employee directory with LeadIQ.

What industry does Magnolia Medical Technologies belong to?

Minus sign iconPlus sign icon
Magnolia Medical Technologies operates in the Medical Equipment Manufacturing industry.

What technology does Magnolia Medical Technologies use?

Minus sign iconPlus sign icon
Magnolia Medical Technologies's tech stack includes Linkedin Insight TagWordPressLiquid WebJavaShowpadreCAPTCHAZURB FoundationTwitter.

What is Magnolia Medical Technologies's email format?

Minus sign iconPlus sign icon
Magnolia Medical Technologies's email format typically follows the pattern of First.Last@magnolia-medical.com. Find more Magnolia Medical Technologies email formats with LeadIQ.

How much funding has Magnolia Medical Technologies raised to date?

Minus sign iconPlus sign icon
As of April 2026, Magnolia Medical Technologies has raised $46M in funding. The last funding round occurred on Feb 16, 2022 for $46M.

When was Magnolia Medical Technologies founded?

Minus sign iconPlus sign icon
Magnolia Medical Technologies was founded in 2006.

Magnolia Medical Technologies

Medical Equipment ManufacturingWashington, United States51-200 Employees

Magnolia Medical Technologies is on a Mission to ZERO®. Today, we offer healthcare institutions a solution to some of their biggest hidden problems – contamination leading to misdiagnosis of bloodstream infections, including sepsis, which can lead to unnecessary and prolonged antibiotic therapy, and false-positive CLABSIs. Tomorrow, we aspire to create a world free of in-vitro diagnostic errors where rapid, accurate test results improve the lives of patients and providers alike.

We know that setting new standards of care is a journey enabled by purposeful innovation, partnerships, and perseverance. As the first step of our journey, we have successfully developed and proven our evidence-based technology platform, Steripath, which we’ve coupled with unparalleled support to change clinical practices and prevent unnecessary patient harm as well as system-wide costs associated with the misdiagnosis of sepsis.

Our mission is further enabled by reducing false-positive CLABSIs and leveraging our extensive intellectual property portfolio – consisting of over 100 issued method, apparatus, and design patents and 70+ patent applications pending – to address other important sources of diagnostic error that are harmful to patients and costly to hospitals.

Section iconCompany Overview

Headquarters
220 West Mercer Street Suite 100 Seattle, Washington 98119 United States
Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $46M

    Magnolia Medical Technologies has raised a total of $46M of funding over 9 rounds. Their latest funding round was raised on Feb 16, 2022 in the amount of $46M.

  • $10M$25M

    Magnolia Medical Technologies's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $46M

    Magnolia Medical Technologies has raised a total of $46M of funding over 9 rounds. Their latest funding round was raised on Feb 16, 2022 in the amount of $46M.

  • $10M$25M

    Magnolia Medical Technologies's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.